Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

PREGABALINA BRILPHARMA 20 MG/ML SOLUCION ORAL EFG - CIMA-AEMPS Drug Approval Details

Approvals/CIMA-AEMPS/PREGABALINA BRILPHARMA 20 MG/ML SOLUCION ORAL EFG

Approved

STANDARD

PREGABALINA BRILPHARMA 20 MG/ML SOLUCION ORAL EFG

Brillpharma (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Date: Feb 15, 2021
Approval ID: ac8f6ca2291cd95a
Company: Brillpharma (Ireland) Limited
Type: Standard

Approval Details

Approval Id: ac8f6ca2291cd95a
Drug Cima Aemps Name: PREGABALINA BRILPHARMA 20 MG/ML SOLUCION ORAL EFG
Register Number: 84171
Holder Company Name: Brillpharma (Ireland) Limited
Marketing Company Name: Brillpharma (Ireland) Limited
Authorization Date: 2021-02-15
Dosage Form: SOLUCIÓN ORAL
Dose: 20 mg/ml
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Brillpharma (Ireland) Limited

Active Ingredients

PREGABALINA

20 mg/ml

Approved

Quick Info

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 15, 2021

Approval ID

ac8f6ca2291cd95a

Type

Standard

Back to CIMA-AEMPS Approvals